Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity. (2021)
Attributed to:
Substrate Peptidomimetic Inhibitors (SPIs) of the COP9 signalosome
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41416-020-01167-y
PubMed Identifier: 33214684
Publication URI: http://europepmc.org/abstract/MED/33214684
Type: Journal Article/Review
Volume: 124
Parent Publication: British journal of cancer
Issue: 4
ISSN: 0007-0920